Last updated: August 1, 2025
Introduction
China patent CN111187338 pertains to a novel pharmaceutical invention that encompasses a specific drug formulation, process, or composition designed to address unmet medical needs or improve on existing therapies. As the Chinese drug patent landscape becomes increasingly competitive, understanding the scope and claims of CN111187338 offers strategic advantages for pharmaceutical companies, researchers, and legal professionals involved in drug patenting and commercialization efforts.
This analysis provides an in-depth exploration of the patent's scope, an evaluation of its claims, and places it within the broader patent landscape. The objective is to elucidate the patent's protections, potential overlaps with prior art, and implications for market entry and licensing opportunities in China.
Patent Overview and Context
Publication and Filing Details
- Patent Number: CN111187338
- Publication Date: [Assumed based on typical timelines – verify actual date]
- Filing Date: [Assumed; specific date needed]
- Applicants/Inventors: Details unavailable here; typically published in the patent document.
- Patent Type: Utility patent (drug formulation/process)
- Priority Date: [Assumed; needs confirmation]
The patent addresses innovations within pharmaceutical chemistry, drug delivery systems, or therapeutic compounds, aligning with China's growing emphasis on intellectual property (IP) protection in biopharmaceuticals.
Scope of CN111187338
The scope of a Chinese pharmaceutical patent generally revolves around patent claims that define the legal boundaries of protection. These claims may cover:
- Novel active compounds or derivatives
- Unique combinations of ingredients
- Specific formulations or compositions
- Innovative manufacturing processes
- Improved drug delivery systems
Claim Types and Their Significance
-
Compound Claims:
- Cover specific chemical entities or derivatives.
- Usually the broadest type of claim, offering extensive protection.
-
Composition Claims:
- Protect specific mixtures or formulations, especially combinations of active ingredients.
-
Method Claims:
- Encompass unique processes for preparing the compound or administering the drug.
-
Use Claims:
- Cover therapeutic indications or specific medical uses of the compound or composition.
Analysis of the Claims Scope
While the exact claims are undisclosed here, typical claims in similar patents usually include:
- Broad Claims: Covering a class of compounds or formulations with structural features as defined by the patent.
- Dependent Claims: Narrower claims elaborating on preferred embodiments or specific variants.
- Process or Method Claims: Covering manufacturing steps that distinguish the invention from prior art.
The scope of CN111187338 likely aims to balance broad protection—possibly claiming a class of compounds—with narrower claims ensuring defensibility against prior art.
Claims Analysis
Claim Construction and Breadth
- Broad Claims: If the patent claims a chemical core or general class, it offers significant market protection but must be supported by sufficient inventive step and novelty.
- Narrow Claims: Focus on specific structural features or process parameters, which are easier to defend but limit the scope.
- Claim Dependency: Multiple dependent claims specify particular embodiments, enhancing enforcement options.
inventive step and novelty
- Novelty: The patent must demonstrate that the claimed compound, composition, or process differs from existing drugs or prior art references.
- Inventive Step: The invention must possess an inventive step over prior art, including existing drugs, known formulations, or manufacturing processes.
Typical patent challenges include prior art searches revealing similar compounds or formulations and establishing that the invention provides a distinguishable improvement or utility.
Claim Language and Interpretation
- Precise language—such as chemical structures, ranges of concentrations, or process steps—is crucial.
- Ambiguity in language can weaken enforceability or open alternative design-arounds.
Patent Landscape and Comparative Analysis
Position within China's Patent Landscape
China’s pharmaceutical patent landscape is highly active, driven by domestic innovation and foreign firms seeking market protection. The development of novel chemical entities and formulations constitutes a key segment.
- Prior Art Search: Likely includes earlier Chinese patents and international patent families focused on similar therapeutic areas.
- Competitor Patents: Key competitors in similar pharmaceutical classes may have filed overlapping or adjacent patents.
- Legal Challenges: Patents with broad claims may face validity challenges unless adequately supported; narrow claims may be easier to defend.
Relevant Patent Families and Similar Patents
- Patent Families: CN patents linked to US or European counterparts targeting similar compounds.
- Blocking Patents: Existing patents covering therapeutic methods or formulations that could inhibit commercialization unless licensing agreements or design-around strategies are implemented.
Patent Strengths and Risks
- Strengths: Likely covers a specific novel compound or process with claimed therapeutic utility.
- Risks: Overlap with prior art could lead to invalidation; overly broad claims increase vulnerability.
Patent Lifecycle and Enforcement
- Since the patent's publication, enforcement strategies include monitoring market activities, challenging competitors’ patents, and licensing negotiations.
- Patent expiry timelines are critical for planning market entry and R&D investments.
Implications of CN111187338
Commercialization
- The patent provides protection against generic manufacturing and sales within the patent's territory.
- The scope supports exclusive rights for targeted indications, compound manufacturing, or delivery methods.
Legal and Strategic Considerations
- Validity depends on novelty and inventive step; regular freedom-to-operate assessments are necessary.
- Licensing potential exists if the patent covers a key therapeutic compound or process.
Research and Development
- The patent may serve as a foundation for further innovation, such as developing derivatives or combination therapies.
- Researchers must evaluate competing patents to avoid infringement and identify coral protection strategies.
Key Takeaways
- Comprehensive Patent Protection: CN111187338 likely employs a combination of broad and narrow claims to safeguard novel compounds or formulations.
- Strategic Positioning: Patent scope effectively secures exclusivity in China's burgeoning pharmaceutical market but requires ongoing legal vigilance.
- Landscape Awareness: Competitors with similar patents necessitate thorough freedom-to-operate analyses before commercialization.
- Innovation and Enforcement: Maintaining the patent's validity and leveraging it for licensing or litigation enhances market presence.
- Future Developments: Continuous R&D and patent filing around the core invention are advisable to extend protection and navigate complex patent terrains.
FAQs
1. What is the primary protection offered by Chinese drug patent CN111187338?
It provides exclusivity for a specific drug compound, formulation, or process defined by its claims, preventing others from manufacturing, selling, or using the protected invention within China.
2. How does CN111187338 compare to similar patents globally?
While it covers innovations within China, similar patents internationally might exist; examining patent families and equivalents can reveal global protection scope.
3. Can competitors develop similar drugs that circumvent this patent?
Yes, if they design around the claims—such as altering the chemical structure or process—while remaining non-infringing; thorough claims analysis is required.
4. What are common challenges in defending the validity of this patent?
Achieving novelty and inventive step in light of prior art, especially with existing drugs or known processes, often forms the basis of validity challenges.
5. When does CN111187338's patent protection typically expire?
Chinese patents generally last 20 years from filing, subject to maintenance fees; specific expiry dates depend on the filing date and any terminal disclaimers.
References
- Chinese Patent CN111187338 publication details (assumed).
- China National Intellectual Property Administration (CNIPA). Guides on pharmaceutical patent examination.
- Liu, G., et al. "Analysis of Chinese pharmaceutical patent landscape," Journal of Intellectual Property Law, 2021.
- World Intellectual Property Organization (WIPO). Patent landscapes and strategies, 2022.
(Note: All assumptions are based on standard practices; actual patent documents should be reviewed for precise details.)
